[HTML] cell.comFull View

[HTML][HTML] Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells

D Blat, E Zigmond, Z Alteber, T Waks, Z Eshhar - Molecular Therapy, 2014 - cell.com
The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat
pathologies that are characterized by aberrant immune activation, including graft rejection …
被引用次数：239 相关文章

Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells

D Blat, E Zigmond, Z Alteber… - … therapy: the journal …, 2014 - pubmed.ncbi.nlm.nih.gov
The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat
pathologies that are characterized by aberrant immune activation, including graft rejection …

Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.

D Blat, E Zigmond, Z Alteber, T Waks… - Molecular Therapy: the …, 2014 - europepmc.org
The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat
pathologies that are characterized by aberrant immune activation, including graft rejection …

Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells

D Blat, E Zigmond, Z Alteber… - Molecular …, 2014 - … .esploro.exlibrisgroup.com
The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat
pathologies that are characterized by aberrant immune activation, including graft rejection …
[HTML] sciencedirect.com

[HTML][HTML] Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells

D Blat, E Zigmond, Z Alteber, T Waks, Z Eshhar - Molecular Therapy, 2014 - Elsevier
The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat
pathologies that are characterized by aberrant immune activation, including graft rejection …

Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells.

D Blat, E Zigmond, Z Alteber, T Waks… - Molecular …, 2014 - search.ebscohost.com
The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat
pathologies that are characterized by aberrant immune activation, including graft rejection …

Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells

D Blat, E Zigmond, Z Alteber… - Molecular …, 2014 - weizmann.esploro.exlibrisgroup.com
The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat
pathologies that are characterized by aberrant immune activation, including graft rejection …
[HTML] nih.gov

[HTML][HTML] Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells

D Blat, E Zigmond, Z Alteber, T Waks… - Molecular Therapy, 2014 - ncbi.nlm.nih.gov
The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat
pathologies that are characterized by aberrant immune activation, including graft rejection …

Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells

D Blat, E Zigmond, Z Alteber, T Waks… - Molecular …, 2014 - search.proquest.com
The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat
pathologies that are characterized by aberrant immune activation, including graft rejection …

Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells

D Blat, E Zigmond, Z Alteber, T Waks… - Molecular …, 2014 - weizmann.elsevierpure.com
The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat
pathologies that are characterized by aberrant immune activation, including graft rejection …